661例未破裂颅内动脉瘤保守治疗:一项跨越40年的观察性研究
该回顾性观察研究分析了1984至2020年间在三级转诊中心保守治疗的661例未破裂颅内动脉瘤患者(共767个动脉瘤),中位随访4.1年,总体动脉瘤相关死亡率为4.4%,年出血率为0.6%,动脉瘤大小及PHASES、ELAPSS评分是出血的独立预测因素。
要点
- 保守观察期间年出血率为0.6%,87%的出血发生在诊断后5年内,10年后无破裂发生。
- PHASES评分<8或ELAPSS评分<15的患者中无动脉瘤相关死亡或破裂发生。
- 动脉瘤大小、PHASES评分和ELAPSS评分是出血的独立预测因素。
核心结论
- PHASES和ELAPSS评分阈值可能有助于识别高风险未破裂颅内动脉瘤患者。
- 个体动脉瘤破裂风险必须与中心特异性治疗结果仔细权衡。
- 对于保守治疗的未破裂颅内动脉瘤,推荐终身定期随访,且在诊断后前10年似乎尤为重要。
研究设计与样本
- 回顾性观察研究,纳入1984年至2020年间在三级转诊中心保守治疗的661例患者共767个未破裂颅内动脉瘤。
- 分析患者特异性和动脉瘤特异性出血及动脉瘤相关死亡的危险因素,包括预先设定的PHASES评分阈值8和ELAPSS评分阈值15。
主要发现
- 保守观察期中位随访4.1年,42%的患者随访≥5年。
- 总体动脉瘤相关死亡率为4.4%。
- 23例(3.5%)患者在保守观察期间发生动脉瘤破裂,总体计算年出血率为0.6%。
- 87%的出血发生在诊断后前5年,10年后无破裂发生。
- 动脉瘤大小、PHASES评分和ELAPSS评分是出血的独立预测因素。
关键数值与推荐
- PHASES评分阈值设定为8,ELAPSS评分阈值设定为15(分析前设定)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The management of unruptured intracranial aneurysms (UIAs) remains controversial, with a scarcity of long-term natural history data on conservative management. Therefore, the authors attempted to identify risk factors for aneurysm rupture in a cohort of consecutive patients with UIAs. METHODS: In this retrospective observational study, the authors analyzed 661 patients with 767 exclusively UIAs who were conservatively managed at their tertiary referral center between 1984 and 2020. Patient-specific and aneurysm-specific risk factors for hemorrhage and aneurysm-related death were analyzed, including thresholds for the PHASES (population, hypertension, age, size of aneurysm, earlier subarachnoid hemorrhage from another aneurysm, and site of aneurysm) and ELAPSS (earlier subarachnoid hemorrhage, aneurysm location, age, population, aneurysm size and shape) scores that were set at 8 and 15, respectively, prior to the analyses. RESULTS: The median follow-up in the conservative observation period was 4.1 years, with 42% of the patients observed for ≥ 5 years. The overall aneurysm-related mortality rate was 4.4%. In 23 (3.5%) patients, aneurysm rupture was reported during the conservative observation period, resulting in an overall calculated annual hemorrhage rate of 0.6%. Notably, 87% of the hemorrhages occurred in the first 5 years after diagnosis, whereas no single rupture occurred after 10 years. Aneurysm size and PHASES and ELAPSS scores were independent predictors of hemorrhage. Among patients with a PHASES score < 8 or an ELAPSS score < 15, no aneurysm-related death or aneurysm rupture occurred. CONCLUSIONS: The identified PHASES and ELAPSS score thresholds may help identify high-risk patients with UIAs. Individual aneurysm rupture risks must be carefully weighed against center-specific treatment outcomes. For conservatively managed UIAs, lifelong regular follow-up is recommended and seems to be especially important in the first 10 years after diagnosis.
引用
- Dodier P, Lederer P, Ecker B, et al. Conservative management of 661 patients with unruptured intracranial aneurysms: an observational study over 4 decades. J Neurosurg. 2025. PMID: 40446344. doi:10.3171/2025.1.JNS241986
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。